Filtros : "CHACRA, NÁDIA ARACI BOU" Limpar

Filtros



Refine with date range


  • Source: Nanomedicine. Unidades: FM, FCFRP, FCF

    Subjects: LEISHMANIA, SISTEMA LINFÁTICO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA, Aline de et al. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine, v. 19, n. 4, p. 293-301, 2024Tradução . . Disponível em: https://dx.doi.org/10.2217/nnm-2023-0263. Acesso em: 28 mar. 2024.
    • APA

      Souza, A. de, Scarim, C. B., Cotrim, P. C., Barbosa Junior, F., Rocha, B. A., Calixto, L. A., et al. (2024). Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine, 19( 4), 293-301. doi:10.2217/nnm-2023-0263
    • NLM

      Souza A de, Scarim CB, Cotrim PC, Barbosa Junior F, Rocha BA, Calixto LA, Correia C de J, Araujo GLB de, Löbenberg R, Bou-Chacra NA, Faloppa ACB. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats [Internet]. Nanomedicine. 2024 ; 19( 4): 293-301.[citado 2024 mar. 28 ] Available from: https://dx.doi.org/10.2217/nnm-2023-0263
    • Vancouver

      Souza A de, Scarim CB, Cotrim PC, Barbosa Junior F, Rocha BA, Calixto LA, Correia C de J, Araujo GLB de, Löbenberg R, Bou-Chacra NA, Faloppa ACB. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats [Internet]. Nanomedicine. 2024 ; 19( 4): 293-301.[citado 2024 mar. 28 ] Available from: https://dx.doi.org/10.2217/nnm-2023-0263
  • Source: Industrial Crops and Products. Unidades: FCF, ICB

    Subjects: NANOPARTÍCULAS, DERMATITE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MASIERO, Jéssica Fagionato et al. Unveiling the optimal path: high-pressure homogenization and D-phase emulsification methods for borage oil nanoemulsion design. Industrial Crops and Products, v. 208, p. 1-10 art. 117853, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.indcrop.2023.117853. Acesso em: 28 mar. 2024.
    • APA

      Masiero, J. F., Knirsch, M. C., Barreto, T. L., Arantes, G. J., Stephano, M. A., Ishida, K., et al. (2024). Unveiling the optimal path: high-pressure homogenization and D-phase emulsification methods for borage oil nanoemulsion design. Industrial Crops and Products, 208, 1-10 art. 117853. doi:10.1016/j.indcrop.2023.117853
    • NLM

      Masiero JF, Knirsch MC, Barreto TL, Arantes GJ, Stephano MA, Ishida K, Löbenberg R, Bou-Chacra NA. Unveiling the optimal path: high-pressure homogenization and D-phase emulsification methods for borage oil nanoemulsion design [Internet]. Industrial Crops and Products. 2024 ; 208 1-10 art. 117853.[citado 2024 mar. 28 ] Available from: https://dx.doi.org/10.1016/j.indcrop.2023.117853
    • Vancouver

      Masiero JF, Knirsch MC, Barreto TL, Arantes GJ, Stephano MA, Ishida K, Löbenberg R, Bou-Chacra NA. Unveiling the optimal path: high-pressure homogenization and D-phase emulsification methods for borage oil nanoemulsion design [Internet]. Industrial Crops and Products. 2024 ; 208 1-10 art. 117853.[citado 2024 mar. 28 ] Available from: https://dx.doi.org/10.1016/j.indcrop.2023.117853
  • Source: International Journal of Pharmaceutics. Unidade: FCF

    Subjects: FÁRMACOS, ANTI-HELMÍNTICOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YUKUYAMA, Megumi Nishitani et al. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions. International Journal of Pharmaceutics, v. 632, p. 1-9 art. 122554, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2022.122554. Acesso em: 28 mar. 2024.
    • APA

      Yukuyama, M. N., Zuo, J., Park, C., Yousef, M., Henostroza, M. A. B., Araujo, G. L. B. de, et al. (2023). Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions. International Journal of Pharmaceutics, 632, 1-9 art. 122554. doi:10.1016/j.ijpharm.2022.122554
    • NLM

      Yukuyama MN, Zuo J, Park C, Yousef M, Henostroza MAB, Araujo GLB de, Bou-Chacra NA, Löbenberg R. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions [Internet]. International Journal of Pharmaceutics. 2023 ; 632 1-9 art. 122554.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122554
    • Vancouver

      Yukuyama MN, Zuo J, Park C, Yousef M, Henostroza MAB, Araujo GLB de, Bou-Chacra NA, Löbenberg R. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions [Internet]. International Journal of Pharmaceutics. 2023 ; 632 1-9 art. 122554.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122554
  • Source: Research in Pharmaceutical Sciences. Unidade: FCF

    Subjects: LISOSSOMOS, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid. Research in Pharmaceutical Sciences, v. 18, n. 1, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.4103/1735-5362.363591. Acesso em: 28 mar. 2024.
    • APA

      Yousef, M., Le, T. S., Zuo, J., Park, C., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2023). Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid. Research in Pharmaceutical Sciences, 18( 1), 1-15. doi:10.4103/1735-5362.363591
    • NLM

      Yousef M, Le TS, Zuo J, Park C, Bou-Chacra NA, Davies NM, Löbenberg R. Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid [Internet]. Research in Pharmaceutical Sciences. 2023 ; 18( 1): 1-15.[citado 2024 mar. 28 ] Available from: https://doi.org/10.4103/1735-5362.363591
    • Vancouver

      Yousef M, Le TS, Zuo J, Park C, Bou-Chacra NA, Davies NM, Löbenberg R. Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid [Internet]. Research in Pharmaceutical Sciences. 2023 ; 18( 1): 1-15.[citado 2024 mar. 28 ] Available from: https://doi.org/10.4103/1735-5362.363591
  • Source: International Journal of Pharmaceutics. Unidade: FCF

    Subjects: QUIMIOTERAPIA, NEOPLASIAS PULMONARES

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MIYAGI, Mariana Yasue Saito et al. Optimizing adjuvant inhaled chemotherapy: synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach. International Journal of Pharmaceutics, v. 644, p. 1-13 art. 123324, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2023.123324. Acesso em: 28 mar. 2024.
    • APA

      Miyagi, M. Y. S., Faria, R. de O., Lameu, C., Souza, G. B. de, Tagami, T., Ozeki, T., et al. (2023). Optimizing adjuvant inhaled chemotherapy: synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach. International Journal of Pharmaceutics, 644, 1-13 art. 123324. doi:10.1016/j.ijpharm.2023.123324
    • NLM

      Miyagi MYS, Faria R de O, Lameu C, Souza GB de, Tagami T, Ozeki T, Bezzon VDN, Yukuyama MN, Bou-Chacra NA, Araujo GLB de. Optimizing adjuvant inhaled chemotherapy: synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach [Internet]. International Journal of Pharmaceutics. 2023 ; 644 1-13 art. 123324.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1016/j.ijpharm.2023.123324
    • Vancouver

      Miyagi MYS, Faria R de O, Lameu C, Souza GB de, Tagami T, Ozeki T, Bezzon VDN, Yukuyama MN, Bou-Chacra NA, Araujo GLB de. Optimizing adjuvant inhaled chemotherapy: synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach [Internet]. International Journal of Pharmaceutics. 2023 ; 644 1-13 art. 123324.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1016/j.ijpharm.2023.123324
  • Source: Chemistry Africa. Unidades: FM, FCF

    Subjects: TRYPANOSOMA CRUZI, FÁRMACOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA, Aline de et al. Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats. Chemistry Africa, v. 6, p. 837-843, 2023Tradução . . Disponível em: https://doi.org/10.1007/s42250-022-00547-6. Acesso em: 28 mar. 2024.
    • APA

      Souza, A. de, Almeida, M. K. L. de, Barbosa, J. A., Yukuyama, M. N., Correia, C. de J., Faloppa, A. C. B., et al. (2023). Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats. Chemistry Africa, 6, 837-843. doi:10.1007/s42250-022-00547-6
    • NLM

      Souza A de, Almeida MKL de, Barbosa JA, Yukuyama MN, Correia C de J, Faloppa ACB, Bou-Chacra NA, Calixto LA. Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats [Internet]. Chemistry Africa. 2023 ; 6 837-843.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1007/s42250-022-00547-6
    • Vancouver

      Souza A de, Almeida MKL de, Barbosa JA, Yukuyama MN, Correia C de J, Faloppa ACB, Bou-Chacra NA, Calixto LA. Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats [Internet]. Chemistry Africa. 2023 ; 6 837-843.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1007/s42250-022-00547-6
  • Source: Resumos. Conference titles: Simpósio Internacional de Iniciação Científica e Tecnológica da USP/SIICUSP. Unidade: FCF

    Subjects: FARMACOTÉCNICA, NEOPLASIAS COLORRETAIS

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MACÁRIO, Guilherme Souza e BOU-CHACRA, Nadia Araci. Nanosuspensão de pirvínio: preparação e caracterização físico-química. 2023, Anais.. São Paulo: Pró-Reitoria de Pesquisa da USP, 2023. Disponível em: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210. Acesso em: 28 mar. 2024.
    • APA

      Macário, G. S., & Bou-Chacra, N. A. (2023). Nanosuspensão de pirvínio: preparação e caracterização físico-química. In Resumos. São Paulo: Pró-Reitoria de Pesquisa da USP. Recuperado de https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
    • NLM

      Macário GS, Bou-Chacra NA. Nanosuspensão de pirvínio: preparação e caracterização físico-química [Internet]. Resumos. 2023 ;[citado 2024 mar. 28 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
    • Vancouver

      Macário GS, Bou-Chacra NA. Nanosuspensão de pirvínio: preparação e caracterização físico-química [Internet]. Resumos. 2023 ;[citado 2024 mar. 28 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: SISTEMA LINFÁTICO, MEDICAMENTO

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons. Pharmaceutics, v. 2, p. 1-17 art. 2532, 2023Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics15112532. Acesso em: 28 mar. 2024.
    • APA

      Yousef, M., Park, C., Henostroza, M., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2023). Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons. Pharmaceutics, 2, 1-17 art. 2532. doi:10.3390/pharmaceutics15112532
    • NLM

      Yousef M, Park C, Henostroza M, Bou-Chacra NA, Davies NM, Löbenberg R. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons [Internet]. Pharmaceutics. 2023 ; 2 1-17 art. 2532.[citado 2024 mar. 28 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112532
    • Vancouver

      Yousef M, Park C, Henostroza M, Bou-Chacra NA, Davies NM, Löbenberg R. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons [Internet]. Pharmaceutics. 2023 ; 2 1-17 art. 2532.[citado 2024 mar. 28 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112532
  • Source: Journal of Cluster Science. Unidades: FCF, IQ

    Subjects: ANTI-HELMÍNTICOS, NEOPLASIAS PULMONARES

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GONÇALVES, Debora de Souza et al. Revisiting flubendazole through nanocrystal technology: statistical design, characterization and its potential inhibitory effect on xenografted lung tumor progression in mice. Journal of Cluster Science, v. 34, n. 1, p. 262-272, 2023Tradução . . Disponível em: https://doi.org/10.1007/s10876-022-02220-x. Acesso em: 28 mar. 2024.
    • APA

      Gonçalves, D. de S., Yukuyama, M. N., Miyagi, M. Y. S., Silva, T. J. V., Lameu, C., Bou-Chacra, N. A., & Araujo, G. L. B. de. (2023). Revisiting flubendazole through nanocrystal technology: statistical design, characterization and its potential inhibitory effect on xenografted lung tumor progression in mice. Journal of Cluster Science, 34( 1), 262-272. doi:10.1007/s10876-022-02220-x
    • NLM

      Gonçalves D de S, Yukuyama MN, Miyagi MYS, Silva TJV, Lameu C, Bou-Chacra NA, Araujo GLB de. Revisiting flubendazole through nanocrystal technology: statistical design, characterization and its potential inhibitory effect on xenografted lung tumor progression in mice [Internet]. Journal of Cluster Science. 2023 ; 34( 1): 262-272.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1007/s10876-022-02220-x
    • Vancouver

      Gonçalves D de S, Yukuyama MN, Miyagi MYS, Silva TJV, Lameu C, Bou-Chacra NA, Araujo GLB de. Revisiting flubendazole through nanocrystal technology: statistical design, characterization and its potential inhibitory effect on xenografted lung tumor progression in mice [Internet]. Journal of Cluster Science. 2023 ; 34( 1): 262-272.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1007/s10876-022-02220-x
  • Source: Journal of Drug Delivery Science and Technology. Unidades: FCF, ESALQ, IQ

    Subjects: ANTINEOPLÁSICOS, MICROTÚBULOS, NANOTECNOLOGIA, NEOPLASIAS PULMONARES

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YUKUYAMA, Megumi Nishitani et al. Unveiling microtubule dynamics in lung cancer: recent findings and prospects for drug delivery and treatment. Journal of Drug Delivery Science and Technology, v. 89, p. 1-14 art. 105017, 2023Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jddst.2023.105017. Acesso em: 28 mar. 2024.
    • APA

      Yukuyama, M. N., Souza, A. de, Henostroza, M. A. B., Araujo, G. L. B. de, Löbenberg, R., Faria, R. de O., et al. (2023). Unveiling microtubule dynamics in lung cancer: recent findings and prospects for drug delivery and treatment. Journal of Drug Delivery Science and Technology, 89, 1-14 art. 105017. doi:10.1016/j.jddst.2023.105017
    • NLM

      Yukuyama MN, Souza A de, Henostroza MAB, Araujo GLB de, Löbenberg R, Faria R de O, Souza GB de, Guimarães LMF, Lameu C, Folchini BR, Peroni CM, Oliveira IF de, Miyagi MYS, Bou-Chacra NA. Unveiling microtubule dynamics in lung cancer: recent findings and prospects for drug delivery and treatment [Internet]. Journal of Drug Delivery Science and Technology. 2023 ; 89 1-14 art. 105017.[citado 2024 mar. 28 ] Available from: https://dx.doi.org/10.1016/j.jddst.2023.105017
    • Vancouver

      Yukuyama MN, Souza A de, Henostroza MAB, Araujo GLB de, Löbenberg R, Faria R de O, Souza GB de, Guimarães LMF, Lameu C, Folchini BR, Peroni CM, Oliveira IF de, Miyagi MYS, Bou-Chacra NA. Unveiling microtubule dynamics in lung cancer: recent findings and prospects for drug delivery and treatment [Internet]. Journal of Drug Delivery Science and Technology. 2023 ; 89 1-14 art. 105017.[citado 2024 mar. 28 ] Available from: https://dx.doi.org/10.1016/j.jddst.2023.105017
  • Source: International Journal of Pharmaceutics. Unidades: FCF, ICB

    Subjects: MICROBIOLOGIA, ANTI-INFECCIOSOS, ANTIBIÓTICOS, NANOPARTÍCULAS, SOLUBILIDADE, MICROSCOPIA ELETRÔNICA DE VARREDURA, DOENÇAS INFECCIOSAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ROCHA, Nataly Paredes da et al. Highly water-soluble dapsone nanocrystals: towards innovative preparations for an undermined drug. International Journal of Pharmaceutics, v. 630, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2022.122428. Acesso em: 28 mar. 2024.
    • APA

      Rocha, N. P. da, Souza, A. de, Yukuyama, M. N., Barreto, T. L., Macedo, L. de O., Löbenberg, R., et al. (2023). Highly water-soluble dapsone nanocrystals: towards innovative preparations for an undermined drug. International Journal of Pharmaceutics, 630, 1-12. doi:10.1016/j.ijpharm.2022.122428
    • NLM

      Rocha NP da, Souza A de, Yukuyama MN, Barreto TL, Macedo L de O, Löbenberg R, Araújo GLB de, Ishida K, Bou-Chacra NA. Highly water-soluble dapsone nanocrystals: towards innovative preparations for an undermined drug [Internet]. International Journal of Pharmaceutics. 2023 ; 630 1-12.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122428
    • Vancouver

      Rocha NP da, Souza A de, Yukuyama MN, Barreto TL, Macedo L de O, Löbenberg R, Araújo GLB de, Ishida K, Bou-Chacra NA. Highly water-soluble dapsone nanocrystals: towards innovative preparations for an undermined drug [Internet]. International Journal of Pharmaceutics. 2023 ; 630 1-12.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122428
  • Source: Applied Chemical Engineering. Unidade: FCF

    Subjects: LIPOPROTEÍNAS, SISTEMA LINFÁTICO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. Lipoproteins within the lymphatic system: Insights into health, disease, and therapeutic implications. Applied Chemical Engineering, v. 6, n. 2, p. 1-7, 2023Tradução . . Disponível em: https://doi.org/10.24294/ace.v6i2.2202. Acesso em: 28 mar. 2024.
    • APA

      Yousef, M., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2023). Lipoproteins within the lymphatic system: Insights into health, disease, and therapeutic implications. Applied Chemical Engineering, 6( 2), 1-7. doi:10.24294/ace.v6i2.2202
    • NLM

      Yousef M, Bou-Chacra NA, Davies NM, Löbenberg R. Lipoproteins within the lymphatic system: Insights into health, disease, and therapeutic implications [Internet]. Applied Chemical Engineering. 2023 ; 6( 2): 1-7.[citado 2024 mar. 28 ] Available from: https://doi.org/10.24294/ace.v6i2.2202
    • Vancouver

      Yousef M, Bou-Chacra NA, Davies NM, Löbenberg R. Lipoproteins within the lymphatic system: Insights into health, disease, and therapeutic implications [Internet]. Applied Chemical Engineering. 2023 ; 6( 2): 1-7.[citado 2024 mar. 28 ] Available from: https://doi.org/10.24294/ace.v6i2.2202
  • Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF

    Subjects: MEDICAMENTO, ANTIRRETROVIRAIS, HIV

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ROCHA, Nataly Paredes da et al. Statistical process control of manufacturing tablets for antiretroviral therapy. Brazilian Journal of Pharmaceutical Sciences, v. 59, p. 1-19 art. e22099, 2023Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902023e22099. Acesso em: 28 mar. 2024.
    • APA

      Rocha, N. P. da, Silva, O. C. da, Barbosa, E. J., Soares, G., Oliveira, R., Monteiro, L. M., & Bou-Chacra, N. A. (2023). Statistical process control of manufacturing tablets for antiretroviral therapy. Brazilian Journal of Pharmaceutical Sciences, 59, 1-19 art. e22099. doi:10.1590/s2175-97902023e22099
    • NLM

      Rocha NP da, Silva OC da, Barbosa EJ, Soares G, Oliveira R, Monteiro LM, Bou-Chacra NA. Statistical process control of manufacturing tablets for antiretroviral therapy [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2023 ; 59 1-19 art. e22099.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1590/s2175-97902023e22099
    • Vancouver

      Rocha NP da, Silva OC da, Barbosa EJ, Soares G, Oliveira R, Monteiro LM, Bou-Chacra NA. Statistical process control of manufacturing tablets for antiretroviral therapy [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2023 ; 59 1-19 art. e22099.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1590/s2175-97902023e22099
  • Source: Drugs Drug Candidates. Unidade: FCF

    Subjects: TRYPANOSOMA CRUZI, LEISHMANIA, NANOTECNOLOGIA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SCARIM, Cauê Benito et al. Synthesis, characterization, and activity of hydroxymethylnitrofurazone nanocrystals against Trypanosoma cruzi and Leishmania spp. Drugs Drug Candidates, v. 1, p. 43–55, 2022Tradução . . Disponível em: https://doi.org/10.3390/ddc1010005. Acesso em: 28 mar. 2024.
    • APA

      Scarim, C. B., Souza, A. de, Marins, D. S. S., Santos, E. G. dos, Castro, L. de F. D., Caldas, I. S., et al. (2022). Synthesis, characterization, and activity of hydroxymethylnitrofurazone nanocrystals against Trypanosoma cruzi and Leishmania spp. Drugs Drug Candidates, 1, 43–55. doi:10.3390/ddc1010005
    • NLM

      Scarim CB, Souza A de, Marins DSS, Santos EG dos, Castro L de FD, Caldas IS, Espuri PF, Marques MJ, Ferreira EI, Bou-Chacra NA, Chin CM. Synthesis, characterization, and activity of hydroxymethylnitrofurazone nanocrystals against Trypanosoma cruzi and Leishmania spp [Internet]. Drugs Drug Candidates. 2022 ; 1 43–55.[citado 2024 mar. 28 ] Available from: https://doi.org/10.3390/ddc1010005
    • Vancouver

      Scarim CB, Souza A de, Marins DSS, Santos EG dos, Castro L de FD, Caldas IS, Espuri PF, Marques MJ, Ferreira EI, Bou-Chacra NA, Chin CM. Synthesis, characterization, and activity of hydroxymethylnitrofurazone nanocrystals against Trypanosoma cruzi and Leishmania spp [Internet]. Drugs Drug Candidates. 2022 ; 1 43–55.[citado 2024 mar. 28 ] Available from: https://doi.org/10.3390/ddc1010005
  • Source: AAPS PharmSciTech. Unidade: FCF

    Subjects: ANTI-INFLAMATÓRIOS, FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HAJJAR, Braa et al. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium. AAPS PharmSciTech, v. 23, p. 1-9 art. 102, 2022Tradução . . Disponível em: https://doi.org/10.1208/s12249-022-02258-0. Acesso em: 28 mar. 2024.
    • APA

      Hajjar, B., Zuo, J., Park, C., Azarmi, S., Silva, D. A., Bou-Chacra, N. A., & Löbenberg, R. (2022). In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium. AAPS PharmSciTech, 23, 1-9 art. 102. doi:10.1208/s12249-022-02258-0
    • NLM

      Hajjar B, Zuo J, Park C, Azarmi S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium [Internet]. AAPS PharmSciTech. 2022 ; 23 1-9 art. 102.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1208/s12249-022-02258-0
    • Vancouver

      Hajjar B, Zuo J, Park C, Azarmi S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium [Internet]. AAPS PharmSciTech. 2022 ; 23 1-9 art. 102.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1208/s12249-022-02258-0
  • Source: Dissolutiom Technologies. Unidade: FCF

    Subjects: FÁRMACOS, SISTEMA LINFÁTICO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development. Dissolutiom Technologies, v. 29, n. 2, p. 86-93, 2022Tradução . . Disponível em: https://doi.org/10.14227/DT290222P86. Acesso em: 28 mar. 2024.
    • APA

      Yousef, M., Park, C., Le, T. S., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2022). Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development. Dissolutiom Technologies, 29( 2), 86-93. doi:10.14227/DT290222P86
    • NLM

      Yousef M, Park C, Le TS, Bou-Chacra NA, Davies NM, Löbenberg R. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development [Internet]. Dissolutiom Technologies. 2022 ; 29( 2): 86-93.[citado 2024 mar. 28 ] Available from: https://doi.org/10.14227/DT290222P86
    • Vancouver

      Yousef M, Park C, Le TS, Bou-Chacra NA, Davies NM, Löbenberg R. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development [Internet]. Dissolutiom Technologies. 2022 ; 29( 2): 86-93.[citado 2024 mar. 28 ] Available from: https://doi.org/10.14227/DT290222P86
  • Source: Jornal da USP. Unidade: FCF

    Subjects: INFECÇÕES OCULARES BACTERIANAS, NANOPARTÍCULAS

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HENOSTROZA, Mirla Anali Bazan e BOU-CHACRA, Nadia Araci. Pesquisadores da USP estudam novas nanoparticulas para tratar infecções bacterianas oculares [Depoimento a Pedro Ferreira]. Jornal da USP. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://jornal.usp.br/ciencias/pesquisadores-da-usp-estudam-novas-nanoparticulas-para-tratar-infeccoes-bacterianas-oculares/#:~:text=Pensando%20em%20solu%C3%A7%C3%B5es%20terap%C3%AAuticas%20mais,carregadas%20com%20antibi%C3%B3ticos%20(LBNs). Acesso em: 28 mar. 2024. , 2022
    • APA

      Henostroza, M. A. B., & Bou-Chacra, N. A. (2022). Pesquisadores da USP estudam novas nanoparticulas para tratar infecções bacterianas oculares [Depoimento a Pedro Ferreira]. Jornal da USP. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de https://jornal.usp.br/ciencias/pesquisadores-da-usp-estudam-novas-nanoparticulas-para-tratar-infeccoes-bacterianas-oculares/#:~:text=Pensando%20em%20solu%C3%A7%C3%B5es%20terap%C3%AAuticas%20mais,carregadas%20com%20antibi%C3%B3ticos%20(LBNs).
    • NLM

      Henostroza MAB, Bou-Chacra NA. Pesquisadores da USP estudam novas nanoparticulas para tratar infecções bacterianas oculares [Depoimento a Pedro Ferreira] [Internet]. Jornal da USP. 2022 ; 1-6.[citado 2024 mar. 28 ] Available from: https://jornal.usp.br/ciencias/pesquisadores-da-usp-estudam-novas-nanoparticulas-para-tratar-infeccoes-bacterianas-oculares/#:~:text=Pensando%20em%20solu%C3%A7%C3%B5es%20terap%C3%AAuticas%20mais,carregadas%20com%20antibi%C3%B3ticos%20(LBNs).
    • Vancouver

      Henostroza MAB, Bou-Chacra NA. Pesquisadores da USP estudam novas nanoparticulas para tratar infecções bacterianas oculares [Depoimento a Pedro Ferreira] [Internet]. Jornal da USP. 2022 ; 1-6.[citado 2024 mar. 28 ] Available from: https://jornal.usp.br/ciencias/pesquisadores-da-usp-estudam-novas-nanoparticulas-para-tratar-infeccoes-bacterianas-oculares/#:~:text=Pensando%20em%20solu%C3%A7%C3%B5es%20terap%C3%AAuticas%20mais,carregadas%20com%20antibi%C3%B3ticos%20(LBNs).
  • Source: International Journal of Pharmaceutics. Unidades: FCF, IGC, IQ

    Subjects: ANTI-HELMÍNTICOS, EXTRUSÃO

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ASSIS, João Marcos Cabral de et al. Hot-melt extrudability of amorphous solid dispersions of flubendazole-copovidone: an exploratory study of the effect of drug loading and the balance of adjuvants on extrudability and dissolution. International Journal of Pharmaceutics, v. 614, p. 1-10 art. 121456, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2022.121456. Acesso em: 28 mar. 2024.
    • APA

      Assis, J. M. C. de, Barbosa, E. J., Bezzon, V. D. N., Lourenço, F. R., Carvalho, F. M. de S., Matos, J. do R., et al. (2022). Hot-melt extrudability of amorphous solid dispersions of flubendazole-copovidone: an exploratory study of the effect of drug loading and the balance of adjuvants on extrudability and dissolution. International Journal of Pharmaceutics, 614, 1-10 art. 121456. doi:10.1016/j.ijpharm.2022.121456
    • NLM

      Assis JMC de, Barbosa EJ, Bezzon VDN, Lourenço FR, Carvalho FM de S, Matos J do R, Bou-Chacra NA, Benmore CJ, Byrn SR, Costa FN, Araujo GLB de. Hot-melt extrudability of amorphous solid dispersions of flubendazole-copovidone: an exploratory study of the effect of drug loading and the balance of adjuvants on extrudability and dissolution [Internet]. International Journal of Pharmaceutics. 2022 ; 614 1-10 art. 121456.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.121456
    • Vancouver

      Assis JMC de, Barbosa EJ, Bezzon VDN, Lourenço FR, Carvalho FM de S, Matos J do R, Bou-Chacra NA, Benmore CJ, Byrn SR, Costa FN, Araujo GLB de. Hot-melt extrudability of amorphous solid dispersions of flubendazole-copovidone: an exploratory study of the effect of drug loading and the balance of adjuvants on extrudability and dissolution [Internet]. International Journal of Pharmaceutics. 2022 ; 614 1-10 art. 121456.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.121456
  • Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF

    Subjects: ANTI-HISTAMÍNICOS H1, ELETROFORESE CAPILAR DE ZONA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MOTHE, Cintia Maria Alves et al. Application of capillary zone electrophoresis to determine second-generation H1 antihistaminic drugs, loratadine and rupatadine. Brazilian Journal of Pharmaceutical Sciences, v. 58, p. 1-9 art. e20767, 2022Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902022e20767. Acesso em: 28 mar. 2024.
    • APA

      Mothe, C. M. A., Souza, A. de, Singh, A. K., Bou-Chacra, N. A., & Aurora-Prado, M. S. (2022). Application of capillary zone electrophoresis to determine second-generation H1 antihistaminic drugs, loratadine and rupatadine. Brazilian Journal of Pharmaceutical Sciences, 58, 1-9 art. e20767. doi:10.1590/s2175-97902022e20767
    • NLM

      Mothe CMA, Souza A de, Singh AK, Bou-Chacra NA, Aurora-Prado MS. Application of capillary zone electrophoresis to determine second-generation H1 antihistaminic drugs, loratadine and rupatadine [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2022 ; 58 1-9 art. e20767.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1590/s2175-97902022e20767
    • Vancouver

      Mothe CMA, Souza A de, Singh AK, Bou-Chacra NA, Aurora-Prado MS. Application of capillary zone electrophoresis to determine second-generation H1 antihistaminic drugs, loratadine and rupatadine [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2022 ; 58 1-9 art. e20767.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1590/s2175-97902022e20767
  • Source: Pharmaceutics. Unidades: FCF, ICB

    Subjects: INFECÇÕES OCULARES, ANTIBIÓTICOS, CONJUNTIVITE VIRAL, NANOTECNOLOGIA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      JESUS, José Izo Santana da Silva de et al. Besifloxacin nanocrystal: towards an innovative ophthalmic preparation. Pharmaceutics, v. 14, p. 1-21 art. 2221, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14102221. Acesso em: 28 mar. 2024.
    • APA

      Jesus, J. I. S. da S. de, Lourenço, F. R., Ishida, K., Barreto, T. L., Avino, V. C., Santos Neto, E. dos, & Bou-Chacra, N. A. (2022). Besifloxacin nanocrystal: towards an innovative ophthalmic preparation. Pharmaceutics, 14, 1-21 art. 2221. doi:10.3390/pharmaceutics14102221
    • NLM

      Jesus JIS da S de, Lourenço FR, Ishida K, Barreto TL, Avino VC, Santos Neto E dos, Bou-Chacra NA. Besifloxacin nanocrystal: towards an innovative ophthalmic preparation [Internet]. Pharmaceutics. 2022 ; 14 1-21 art. 2221.[citado 2024 mar. 28 ] Available from: https://doi.org/10.3390/pharmaceutics14102221
    • Vancouver

      Jesus JIS da S de, Lourenço FR, Ishida K, Barreto TL, Avino VC, Santos Neto E dos, Bou-Chacra NA. Besifloxacin nanocrystal: towards an innovative ophthalmic preparation [Internet]. Pharmaceutics. 2022 ; 14 1-21 art. 2221.[citado 2024 mar. 28 ] Available from: https://doi.org/10.3390/pharmaceutics14102221

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024